Prudential Financial’s Korro Bio KRRO Stock Holding History

Prudential Financial’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-474	Closed	-$36K	–	2687
2022 Q2	$36K	Buy	+474	New	+$32K	﹤0.01%	2592

Other funds holding KRRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Prudential Financial's KRRO Position: Q3 2022 in Review

Prudential Financial sold out of Korro Bio (KRRO) in Q3 2022, closing a stake of 474 shares — an estimated $36K sold.

Prudential Financial first reported a position in KRRO in Q2 2022 and held it in 1 quarter. The position peaked at $36K in Q2 2022. 55 funds tracked by Wall St. Rank hold KRRO as of Q3 2022.

Prudential Financial reported no remaining Korro Bio position as of Q3 2022 after selling out during the quarter.
Prudential Financial sold 474 Korro Bio shares in Q3 2022, an estimated $36K.
Prudential Financial first reported a position in Korro Bio in Q2 2022 and held it in 1 quarter.
Prudential Financial's Korro Bio position peaked at $36K in Q2 2022.
55 funds tracked by Wall St. Rank held Korro Bio as of Q3 2022.

Based on Prudential Financial's 13F filing for Q3 2022, filed 4 Nov 2022.